Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Orale Budesonide in the Prevention of Acute Gastrointestinal Graft-versus-host Disease Following Allogenic Stem Cell Transplantation

NCT00180089 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT00180089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00180089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Orale Budesonide in the Prevention of Acute Gastrointestinal Graft-versus-host Disease Following Allogenic Stem Cell Transplantation
Lead sponsor
Technische Universität Dresden
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
January 31, 2010
Enrollment
242 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host disease, leukemia